The A/G polymorphism in the - 78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1398, Issue 1, 1998, Pages 67-74

  Danek, Giorgia Maria ^a   Valenti, Marina ^a   Baralle, Francisco E ^a   Romano, Maurizio ^a,b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Apolipoprotein; Gene expression; Polymorphism; Promoter

Indexed keywords

APOLIPOPROTEIN A1;

ALLELE; ARTICLE; ATHEROSCLEROSIS; EPITHELIUM CELL; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION;

ADENINE; APOLIPOPROTEIN A-I; GUANINE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032577656     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(98)00029-3     Document Type: Article

References (35)

1. A. Wu, H. Windmueller, Raative contributions by liver and intestine to individual plasma apolipoproteins in the rat, J. Biol. Chem. 254 (1979) 7316-7322.
2. M. Sorci-Thomas, M. Prack, N. Dashti, F. Johnson, L. Rudel, D. Williams, Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density, J. Lipid Res. 30 (1989) 1397-1403.
3. A.J. Gotto, H. Pownall, R. Have, Introduction to the plasma lipoproteins, Meth. Enzymol. 128 (1986) 3-41.
4. C.J. Fielding, V.G. Shore, P.E. Fielding, Lecithin: cholesterol acyltransferase: effects of substrate composition upon enzyme activity, Biochim. Biophys. Acta 270 (1972) 513-518.
5. A.K. Soutar, C.W. Garner, H.N. Baker, J.T. Sparrow, R.L. Jackson, A.M. Gotto, L.C. Smith, Effect of the human plasma apolipoproteins and phosphatidylcholine acyldonor on the activity of lecithin: cholesterol acyltransferase, Biochemistry 4 (1975) 3057-3064.
6. R. Wlliamson, D. Lee, J. Hagaman, N. Maeda, Marked reduction of high density lipoprota n cholesterol in mice genetically modified to lack apolipoprotein A-I, Proc. Natl. Acad. Sci. USA 89 (1992) 7134-7138.
7. J. Segrest, G. Anantharamaiah, Pathogenesis of atherosclerosis, Curr. Opin. Cardiol. 9 (1994) 404-410.
8. J.L. Breslow, Mouse modes of atherosclerosis, Science 272 (1996) 685-688.
9. T. Forte, M. McCall, The role of apolipoprotein A-I-containing lipoprotans in atherosclerosis, Curr. Opin. Lipidol. 5 (1994) 354-364.
10. R. Neary, D. Bhatnagar, P. Durrington, M. Ishola, S. Arrol, M. Mackness, An investigation of the role of lecithin: cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins, Atherosclerosis 89 (1991) 35-48.
11. W. Davidson, T. Hazlett, W. Mantulin, A. Jonas, The role of apolipoprotein Al domains in lipid binding, Proc. Natl. Acad. Sci. USA 93 (1996) 13605-13610.
12. F. Pagani, A. Sdoli, G.A. Giudici, L. Barenghi, C. Vergani, F.E. Baralle, Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoprotanemia, J. Lipid Res. 31 (1990) 1371-1377.
13. S. McKnight, R. Kingsbury, Transcriptional control signals of a eukaryotic protan-coding gene, Science 217 (1982) 316-324.
14. K. Higuchi, S. Law, J. Hoeg, S. UK, N. Meglin, H.J. Brewer, Tissue-specific expression of apolipoprotein A-I (Apo A-I) is regulated by the 5′-flanking region of the human ApoAl gene, J. Biol. Chem. 263 (1988) 18530-18536.
15. P.J. Talmud, S. Ye, S.E. Humphries, Polymorphism in the promoter region of the apolipoprotein Al gene associated with differences in apolipoprotein AI levas: the European atherosclerosis research study, Genet. Epidemiol. 11 (1994) 265-280.
16. N. Saha, J.S. Tay, P.S. Low, S.E. Humphries, Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levas in Chinese non-smokers, Genet. Epidemiol. 11 (1994) 255-264.
17. F. Pagani, G.A. Giudici, F.E. Baralle, C. Vergani, Association of a polymorphism in the ApoAl gene promoter with hyperalphalipoprotanemia, Eur. J. Epidemiol. 8 (1992) 54-58.
18. R. Tuteja, N. Tuteja, C. Melo, G. Casari, F.E. Baralle, Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition, FEBS Lett. 304 (1992) 98-101.
19. E. Angotti, E. Mele, F. Costanzo, E.V. Avvedimento, A polymorphism (G → A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency, J. Biol. Chem. 269 (1994) 17371-17374.
20. J.D. Smith, E.A. Brinton, J.L. Breslow, Polymorphism in the human apolipoprotein A-I gene promoter region: association of the minor allele with decreased production rate in vivo and promoter activity in vitro, J. Clin. Invest. 89 (1992) 1796-1800.
21. D.E. Barre, R. Guerra, R. Verstraete, Z. Wang, S.M. Grundy, J.C. Cohen, Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levas, J. Lipid Res. 35 (1994) 1292-1296.
22. J. Lopez-Miranda, J.M. Ordovas, A. Espino, C. Marin, J. Salas, F. Lopez-Segura, J. Jimenez-Pereperez, F. Perez-Jimenez, Influence of mutation in human apolipoprotan A-1 gene promoter on plasma LDL cholesterol response to dietary fat, Lancet 343 (1994) 1246-1249.
23. P.W. Wilson, K.N. Anderson, T. Harris, W.B. Kannel, W.P. Casteli, Determinants of change in total cholesterol and HDL-C with age: the Framingham study, J. Gerontol. 49 (1994) M252-M257.
24. J.L. Breslow, S. Eisemberg, E.A. Brinton, Metabolic determinants of low HDL-C levas, Ann. NY Acad. Sci. 676 (1993) 157-162.
25. C. R. Sharpe, Genes for human apolipoproteins, PhD Thesis, Oxford, 1985.
26. C.C. Shoulders, F.E. Baralle, Isolation of the human HDL apolipoprotein A1 gene, Nucleic Acids Res. 10 (1982) 4873-4882.
27. C.C. Shoulders, A.R. Kornblihtt, B.S. Munro, F.E. Baralle, Gene structure of human apolipoprotein A1, Nucleic Acids Res. 11 (1983) 2827-2837.
28. S.P. Tam, T.K. Archer, R.G. Deeley, Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2, J. Biol. Chem. 260 (1985) 1670-1675.
29. S.P. Tam, T.K. Archer, R.G. Deeley, Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone, Proc. Natl. Acad. Sci. USA 83 (1986) 3111-3115.
30. S.P. Tam, T.K. Archer, R.G. Deeley, Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cals, J. Biol. Chem. 261 (1986) 5067-5074.
31. T. Giller, U. Hennes, H.J. Kempen, Regulation of human apolipoprotein A-I expression in Caco-2and HepG2 cells by all-trans and 9-cis retinoic acids, J. Lipid Res. 36 (1995) 1021-1028.
32. L. Berthou, B. Staals, I. Saldicco, K. Berthelot, J. Casey, J.C. Fruchart, P. Denefle, D. Branellec, Opposite in vitro and in vivo regulation of hepatic apolipoprotein A-I gene expression by retinoic add: absence of effects on apolipoprotan A-II gene expression, Arterioscler. Thromb. 14 (1994) 1657-1664.
33. K.N. Sastry, U. Seedorf, S.K. Karathanasis, Different cisacting DNA elements control expression of the human apolipoprotein Al gene in different cell types, Mol. Cell Biol. 8 (1988) 605-614.
34. P. Papazafiri, K. Ogami, D.P. Ramji, A. Nicosia, P. Monad, C. Cladaras, V.I. Zannis, Promoter elements and factors involved in hepatic transcription of the human Apo A-I gene positive and negative regulators bind to overlapping sites, J. Biol Chem. 266 (1991) 5790-5797.
35. G.S. Ginsburg, J. Ozer, S.K. Karathanasis, Intestinal apolipoprotein Al gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4, J. Clin. Invest. 96 (1995) 528-538.